GLOBUS MEDICAL INC acquired NuVasive, Inc. for Stock-for-stock merger at a fixed exchange ratio of 0.75 Globus Medical share per NuVasive share; pro forma ownership ~72% Globus Medical / ~28% NuVasive shareholders, a transaction completed in September 2023, structured as all stock. The deal was a Merger.
NuVasive, Inc. operates in Spine & musculoskeletal — spine implants and enabling technology, is based in San Diego, California, USA. NuVasive, Inc. is a San Diego-based global medical technology company focused on spine surgery, known for its lateral access procedures and the Pulse enabling-technology platform spanning surgical planning, navigation, imaging and intraoperative neuromonitoring.
Combining to create a leading global musculoskeletal company with complementary global scale, expanded commercial reach, comprehensive portfolios in spine and orthopedics, and increased operational capabilities.
Complementary spine portfolio and the Pulse enabling-technology platform, roughly doubling Globus Medical's scale and adding lateral-access expertise and broader commercial reach. Combined under Globus Medical (NYSE: GMED), with David Paul as Executive Chairman and Dan Scavilla as CEO Dan Scavilla, President and CEO, Globus Medical (Sept 1, 2023 completion release): "We're thrilled to begin our journey together to create a leading global musculoskeletal company. With a relentless focus on changing patient lives, we're combining our differentiated portfolios and talented teams to reach more customers as we advance spine and orthopedic care globally."
Our combination with NuVasive is a defining moment in our company's history. I'm incredibly proud of the strong legacy we've built at Globus Medical, and I look forward to delivering on the many opportunities for our surgeon customers and their patients as a combined company.David Paul, Executive Chairman, Globus Medical
The combination with Globus Medical is highly transformative-bringing together two leading companies with a shared vision to change the lives of more patients around the globe. I look forward to helping the combined organization transform the future of surgery.Chris Barry, former Chief Executive Officer, NuVasive
Advisory firms were not disclosed for this transaction.